(Q40252024)

English

Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.

scientific article published on August 2006

Statements

Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. (English)
0 references
0 references
Jeffrey M Albert
Carolyn Cao
Ling Geng
Lauren Leavitt
Dennis E Hallahan
1 August 2006
1536-1543

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit